Evaluation of ovulation induction protocols for poor responders undergoing assisted reproduction techniques

Saudi Medical Journal

Volumn 26, Issue 4, 2005, Pages 593-596

  Ashrafi, Mahnaz ^a   Ashtiani, Saeid K ^a   Zafarani, Fatemeh ^a   Samani, Reza O ^a   Eshrati, Babak ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE; GONADORELIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE;

AMPOULE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; FERTILIZATION IN VITRO; HORMONAL REGULATION; HUMAN; HYPOPHYSIS; INCIDENCE; INFERTILITY THERAPY; INTERMETHOD COMPARISON; IRAN; LUTEAL PHASE; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; OOCYTE MATURATION; OVARY CYCLE; OVULATION INDUCTION; RANDOMIZED CONTROLLED TRIAL;

FEMALE; FERTILIZATION IN VITRO; HUMANS; OVULATION INDUCTION; PROSPECTIVE STUDIES;

EID: 19044363386     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pellicer A, Simon C, Miro F, Castellvi RM, Ruiz A, Ruiz M, et al. Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotrophin-releasing hormone analogues in different phases of the menstrual cycle. Hum Reprod 1989; 4: 285-289.
2. Fasouliotis SJ, Simon A, Laufer N. Evaluation and treatment of low responders in assisted reproductive technology: A challenge to meet. J Assist Reprod Genet 2000; 17: 335-373.
3. Surrey ES, Schoolcraft WB. Evaluation strategies for improving ovarian response of the poor responders undergoing assisted reproductive techniques. Fertil Steril 2000; 73: 667-676.
4. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003; 9: 61-76.
5. Fleming R, Adam AH, Barlow OH, Black WP, MacNaughton MC, Coutts JR. A new systemic treatment for infertile women with abnormal hormone profiles. Br J Obstet Gynecol 1982; 89: 80-83.
6. Leung PCK. GnRH receptor and potential action in human ovary. Gynecol Endocrinol 1999; 13:10.
7. Pinkas H, Orvieto R, Avrech OM, Rufas O, Ferber A, Ben-Rafael Z et al. Gonadotropin stimulation following GnRH-a priming for poor responders in in vitro fertilization-embryo transfer programs. Gynecol Endocrinol 2000; 14: 11-14.
8. Serafini P, Stone B, Kerin J, Batzofin J, Quinn P, Marrs RP. An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril 1988; 49: 90-95.
9. Cummins JM, Yovich JM, Edirisinghe WR, Yovich JL. Pituitary down regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)- related treatments. J In Vitro Fert Embryo Transf 1989; 6: 345-352.
10. Feldberg D, Farhi J, Ashkenazi J, Dicker D, Shalev J, Ben-Rafael Z. Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994; 62: 343-346.
11. Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu HC, et al. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989; 51: 292-297.
12. Ben-Rafael Z, Lipitz S, Bider D, Mashiach S. Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels. Fertil Steril 1991; 55: 272-275.
13. Scott RT, Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994; 61: 880-885.
14. Schoolcraft W, Schlenker T, Gee M, Stevens J, Wagley L. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle- stimulating hormone flare, growth hormone protocol. Fertil Steril 1997; 67: 93-97.
15. Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998; 9: 419-424.
16. Garcia JE, Padilla SL, Bayati J, Baramki TA. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Fertil Steril 1990; 53: 302-305.
17. Katayama KP, Roesler M, Gunnarson C, Stehlik E, Jagusch S. Short-term use of gonadotropin-releasing hormone agonist (leuprolide) for in vitro fertilization. J In Vitro Fert Embryo Transf 1988; 5: 332-334.
18. Toth TL, Awwad JT, Veeck LL, Jones HW Jr, Muasher SJ. Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program. J Reprod Med 1996; 41: 321-326.
19. Faber BM, Mayer J, Cox B, Jones D, Toner JP, Oehninger S, et al. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril 1998; 69: 826-830.
20. Bider D, Ben-Rafael Z, Shalev J, Goldenberg M, Mashiach S, Blankstein J. Pituitary and ovarian suppression rate after high dosage of gonadotropin-releasing hormone agonist. Fertil Steril 1989; 51: 578-581.
21. Tavaniotou A, Albano C, Van Steirteghem A, Devroey P. The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix. Reprod Biomed Online 2003; 6: 421-426.
22. Abdalla HI, Ahuja KK, Leonard T, Morris NN, Honour JW, Jacobs HS. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program. Fertil Steril 1990; 53: 473-478.
23. Caspi E, Ron-El R, Golan A, Nachum H, Herman A, Soffer Y, et al. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins. Fertil Steril 1989; 51: 95-99.
24. Dhont M, Onghena A, Coetsier T, De Sutter P. Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction. Hum Reprod 1995; 10: 791-796.
25. Horvath PM, Styler M, Hammond JM, Shelden RM, Kemmann E. Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation. Fertil Steril 1988; 49: 159-162.